Table 4. Initial immunosuppressive therapy in patients with SRNS.
MCNS | FSGS | DMP | MPGN | MN | TOTAL | |
---|---|---|---|---|---|---|
CsA | 5 | 6 | 1 | 1 | 13 (59.1%) | |
CYC | 3 | 1 | 2 | 3 | 9 (40.9%) | |
TOTAL | 8 | 7 | 3 | 3 | 1 | 22 (100.0%) |
MCNS | FSGS | DMP | MPGN | MN | TOTAL | |
---|---|---|---|---|---|---|
CsA | 5 | 6 | 1 | 1 | 13 (59.1%) | |
CYC | 3 | 1 | 2 | 3 | 9 (40.9%) | |
TOTAL | 8 | 7 | 3 | 3 | 1 | 22 (100.0%) |